×
About 605 results

ALLMedicine™ Meningococcal Meningitis Center

Research & Reviews  171 results

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in Ch...
https://doi.org/10.1080/21645515.2022.2071077
Human Vaccines & Immunotherapeutics; Xu J, Chen Y et. al.

Jun 11th, 2022 - Invasive meningococcal disease (IMD) caused by Neisseria meningitidis (Nm) continues to be a global public health concern. Understanding the prevalence of Nm serogroups in IMD is critical for developing strategies for meningococcal vaccination. We...

Long-term impact of invasive meningococcal disease in children: SEINE study protocol.
https://doi.org/10.1371/journal.pone.0268536
PloS One; Baloche A, Jung C et. al.

May 27th, 2022 - Invasive meningococcal disease (IMD) is still an important cause of mortality in children and survivors can have significant long-term disabling sequelae. There are few prospective studies looking at the long term neuropsychological and developmen...

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccin...
https://doi.org/10.1016/j.vaccine.2022.05.032
Vaccine Chang CM, Awanye AM et. al.

May 25th, 2022 - Meningococcal meningitis is a rare but serious condition affecting mainly children and young adults. Outer membrane vesicles (OMV) from Neisseria meningitidis have been used successfully as vaccines against the disease, although they only provide ...

A database study of clinical and economic burden of invasive meningococcal disease in F...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053794
PloS One; Huang L, Fievez S et. al.

Apr 30th, 2022 - Invasive meningococcal disease (IMD) is life-threatening and associated with substantial morbidity and mortality. The study aimed to examine the clinical characteristics and hospital-based healthcare resource use and related costs following IMD di...

One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123035
Advances in Therapy; Duval X, Taha MK et. al.

Apr 29th, 2022 - COMBAT is a prospective, multicentre cohort study that enrolled consecutive adults with community-acquired bacterial meningitis (CABM) in 69 participating centres in France between February 2013 and July 2015 and followed them for 1 year. Patients...

see more →

Drugs  36 results see all →

Clinicaltrials.gov  13 results

Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine
https://clinicaltrials.gov/ct2/show/NCT05093829

Apr 7th, 2022 - Meningococcal meningitis, caused by invasive strains of Neisseria meningitidis, is a major public health concern because of its considerable morbidity and mortality in sub-Saharan Africa. Case fatality during meningococcal meningitis epidemics can...

Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans
https://clinicaltrials.gov/ct2/show/NCT04685850

Aug 5th, 2021 - While the initial evolution of meningococcal meningitis (MM) is well described, there are few data on the long-term evolution, beyond 1 year. The objective of this research is to evaluate the sequelae of MM beyond 1 year in patients with a history...

Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French Overseas Departments (Martinique, Guadeloupe, French Guiana, Reun...
https://clinicaltrials.gov/ct2/show/NCT04211649

Dec 26th, 2019 - Leptospirosis is a globally distributed neglected tropical disease affecting subtropical and tropical areas, such as the Caribbean and the Indian Ocean, with favorable climatic conditions for disease transmission. It shows a strong seasonality, wi...

Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018
https://clinicaltrials.gov/ct2/show/NCT03431675

Aug 14th, 2019 - The study is designed as a cluster-randomized trial in the setting of a meningitis epidemic to assess the impact of chemoprophylaxis with single-dose ciprofloxacin on the incidence of meningitis in the study area. The study will be implemented in ...

Evaluation of Different Methods for Diagnosis of ME
https://clinicaltrials.gov/ct2/show/NCT03759470

Nov 30th, 2018 - meningitis is a notifiable disease in many countries, the exact incidence rate is unknown. In 2013 meningitis resulted in 303,000 deaths - down from 464,000 deaths in 1990. In 2010 it was estimated that meningitis resulted in 420,000 deaths, exclu...

see more →

News  21 results

Role of Leptin in the MASP-2 Pathway
https://www.onclive.com/view/role-of-leptin-in-the-masp-2-pathway

Apr 26th, 2021 - Samer Khaled, MD: We’ll move on to our next segment and talk about an evolving novel therapy that’s being introduced by Omeros. This is a MASP-2 [mannan-binding lectin serine protease] inhibitor that inhibits the lectin pathway. Just to start with...

ACIP recommendations for COVID-19 vaccines—and more
https://www.mdedge.com/familymedicine/article/236738/preventive-care/acip-recommendations-covid-19-vaccines-and-more
MDedge Family Medicine; Doug Campos-Outcalt, MD, MPA

Mar 4th, 2021 - The year 2020 was challenging for public health agencies and especially for the Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP). In a normal year, the ACIP meets in person 3 times for a.

5 Things to Know About Meningococcal Disease
https://www.staging.medscape.com/viewarticle/940754

Nov 11th, 2020 - Neisseria meningitidis (meningococcus) is a leading cause of bacterial meningitis and septicemia, with about 1.2 million cases of infection and 135,000 deaths globally each year. Because death can rapidly follow infection, cases should be consider...

5 Things to Know About Meningococcal Disease
https://www.medscape.com/viewarticle/940754

Nov 11th, 2020 - Neisseria meningitidis (meningococcus) is a leading cause of bacterial meningitis and septicemia, with about 1.2 million cases of infection and 135,000 deaths globally each year. Because death can rapidly follow infection, cases should be consider...

English infant quadravalent group B meningococcal vaccine pays off
https://www.mdedge.com/infectiousdisease/article/141684/vaccines/english-infant-quadravalent-group-b-meningococcal-vaccine
Bruce Jancin

Jun 30th, 2017 - MADRID – Cases of invasive meningococcal disease in English 1 year olds dropped fourfold in the first year after the multicomponent group B meningococcal (MenB) vaccine (4CMenB, Bexsero) was added to the national infant immunization list, Shamez L.

see more →

Patient Education  1 results see all →